Topic: neurodegenerative diseases
A connection between TDP-43, which has been implicated in ALS, and another gene could yield new approaches to treating the disease.
The partners will work to develop adeno-associated virus vectors capable of crossing the blood-brain barrier.
A discovery of a mechanism that clears the toxic brain protein tau could lead to new ideas for treating Alzheimer's.
Rheostat Therapeutics raised $23 million to develop treatments for neurodegenerative and rare diseases by targeting the cell’s garbage disposal.
After refocusing on gene therapy, Axovant is appointing five new executives to posts ranging from clinical development to commercial operations.
UB-312 prevented the accumulation of misfolded alpha-synuclein proteins in cell and animal models of Parkinson's disease.
The agreement covers small molecules designed to treat multiple neurodegenerative and systemic inflammatory diseases.
Protein clumps that occur in both the gut and the brain could be prime targets for Parkinson's therapies, new research suggests.
A Tufts University-led team has developed 3D models of the central nervous system that might prove useful for drug discovery.
Researchers accidentally reprogrammed mature neurons into dopamine-producing neurons—a discovery that could spark new therapies for brain diseases.